Company Overview

Horimed Technology Co., Ltd. is a medical device company founded in 2016 that specializes in the development, production, and sales of advanced intravascular imaging equipment. The company's core products include Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS) systems and catheters. Horimed aims to provide comprehensive pan-vascular solutions based on its imaging products for both domestic and international markets. The company has a significant focus on research and development, possessing numerous patents and a team with expertise in optics, electronics, and medical technologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

intravascular imagingoptical coherence tomographyOCTintravascular ultrasoundIVUSdisposable cathetersinterventional cardiologycath lab equipmentcoronary artery imagingmedical capital equipmentintegrated IVUS OCToptical biopsynon-invasive fractional flow reserveFFRstent placement guidancevascular imagingmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Horimed Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Horimed Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Mar 22, 2024
Series B	Oct 19, 2020
Early Funding	Jul 6, 2019

View all Funding Rounds

Horimed Investors

Notable investors and investment history

Investor	Rounds
YuanBio Venture Capital	Early Funding
3H Health Investment	Series B
Legend Capital	Series B
Beiyang Haitang Venture Capital Fund	Early Funding
Tasly Capital	Series C
Haihe River Industry Fund	Series C

View all Investors

Horimed Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Horimed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Horimed's valuation, stock price, and market status.

Firmographic Details

HeadquartersTianjin, Tianjin

Year Founded2016

Last FundingMar 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.